CDKV Holdings’s Viatris VTRS Stock Holding History

CDKV Holdings’s Portfolio VTRS Stock Details VTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.83K	Hold	493	–	–	0.01%	223
2026 Q1	$6.66K	Hold	493	–	–	0.01%	222
2025 Q4	$6.14K	Buy	+493	New	+$5.32K	0.01%	226

Other funds holding VTRS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CDKV Holdings's VTRS Position: Q2 2026 in Review

CDKV Holdings held its Viatris (VTRS) position steady in Q2 2026 at 493 shares worth $7.83K. The position accounts for 0.01% of the portfolio, ranked #223.

CDKV Holdings first reported a position in VTRS in Q4 2025 and has held it in 3 quarters since. 1,024 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

CDKV Holdings held 493 shares of Viatris worth $7.83K as of Q2 2026.
CDKV Holdings left its Viatris share count unchanged in Q2 2026.
Viatris made up 0.01% of CDKV Holdings's portfolio in Q2 2026, its #223 holding.
CDKV Holdings first reported a position in Viatris in Q4 2025 and has held it in 3 quarters since.
1,024 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on CDKV Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.